Attached files

file filename
8-K - 8-K - VEECO INSTRUMENTS INCa16-4875_18k.htm
EX-99.2 - EX-99.2 - VEECO INSTRUMENTS INCa16-4875_1ex99d2.htm

EXHIBIT 99.1

 

NEWS

 

VEECO REPORTS FOURTH QUARTER AND FISCAL YEAR 2015 FINANCIAL RESULTS

 

Fourth Quarter 2015 Highlights

 

·                  Revenues of $106.5 million, down 6% compared with the same period last year

·                  GAAP net loss per share of $0.25 and Non-GAAP earnings per share of $0.01

·                  Non-GAAP adjusted EBITDA of $4.4 million

 

Full Year 2015 Highlights

 

·                  Revenues of $477.0 million, an increase of 21% compared to 2014

·                  GAAP net loss per share of $0.80 and Non-GAAP earnings per share of $0.54

·                  Non-GAAP adjusted EBITDA of $41.7 million

 

Plainview, N.Y., February 22, 2016 — Veeco Instruments Inc. (Nasdaq: VECO) announced financial results for its fourth quarter and fiscal year ended December 31, 2015. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”).

 

A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.

 

U.S. Dollars in millions, except per share data

 

 

 

4th Quarter

 

Full Year

 

GAAP Results

 

Q4 ‘15

 

Q4 ‘14

 

2015

 

2014

 

Revenue

 

$

106.5

 

$

113.6

 

$

477.0

 

$

392.9

 

Net income (loss)

 

$

(9.8

)

$

(56.9

)

$

(32.0

)

$

(66.9

)

Diluted earnings (loss) per share

 

$

(0.25

)

$

(1.44

)

$

(0.80

)

$

(1.70

)

 

 

 

4th Quarter

 

Full Year

 

Non-GAAP Results

 

Q4 ‘15

 

Q4 ‘14

 

2015

 

2014

 

Adjusted EBITDA

 

$

4.4

 

$

8.3

 

$

41.7

 

$

2.6

 

Net income (loss)

 

$

0.6

 

$

5.1

 

$

22.1

 

$

(4.1

)

Diluted earnings (loss) per share

 

$

0.01

 

$

0.13

 

$

0.54

 

$

(0.10

)

 

“We ended 2015 on a positive note, delivering solid Q4 revenue and adjusted EBITDA and exceeding the high end of our guidance range for gross margin. Q4 bookings doubled sequentially to $107 million, bolstered by record-level orders for our Precision Surface Processing (“PSP”) products. PSP has enabled us to significantly expand our footprint in the RF and MEMS markets and also gain entry into the high growth Advanced Packaging space.  With focus and execution, we exceeded our 2015 revenue plans for PSP which contributed to annual revenue growth of 21 percent for the company,” commented John R. Peeler, Chairman and Chief Executive Officer.

 

“Entering 2016, we continue to face a weak macro-economic environment and challenging LED industry conditions.  As a result, we expect investments for Metal Organic Chemical Vapor Deposition (“MOCVD”) equipment will remain soft through the first half of this year.  During this time, we continue to strengthen our product portfolio and recently introduced the TurboDisc® K475iTM MOCVD reactor to complement our industry leading EPIKTM 700 MOCVD product. We remain focused on positioning the Company for long term growth and are encouraged by our prospects,” Mr. Peeler concluded.

 



 

Guidance and Outlook

 

The following guidance is provided for Veeco’s first quarter 2016:

 

·                  Revenue is expected to be in the range of $70 million to $80 million

·                  Adjusted EBITDA (loss) is expected to be in the range of ($9) million to ($5) million

·                  GAAP earnings (loss) per share are expected to be in the range of ($0.62) to ($0.52)

·                  Non-GAAP earnings (loss) per share are expected to be in the range of ($0.35) to ($0.25)

 

Please refer to the tables at the end of this press release for further details.

 

Conference Call Information

 

A conference call reviewing these results has been scheduled for today, February 22, 2016 starting at 5:00pm ET. To join the call, dial 1-888-438-5491 (toll free) or 1-719-785-1765 and use passcode 4400150. The call will also be webcast live on the Veeco website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00pm ET this evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

 

About Veeco

 

Veeco’s process equipment solutions enable the manufacture of LEDs, displays, power electronics, compound semiconductors, hard disk drives, semiconductors, MEMS and wireless chips. We are the leader in MOCVD, MBE, Ion Beam, Wet Etch single wafer processing and other advanced thin film process technologies. Our high performance systems drive innovation in energy efficiency, consumer electronics and network storage and allow our customers to maximize productivity and achieve lower cost of ownership. For information on our company, products and worldwide service and support, please visit www.veeco.com.

 

To the extent that this news release discusses expectations or otherwise makes statements about the future, such statements are forward-looking and are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include the risks discussed in the Business Description and Management’s Discussion and Analysis sections of Veeco’s Annual Report on Form 10-K for the year ended December 31, 2014 and in our subsequent quarterly reports on Form 10-Q, current reports on Form 8-K and press releases. Veeco does not undertake any obligation to update any forward-looking statements to reflect future events or circumstances after the date of such statements.

 

-financial tables attached-

 

Veeco Contacts:

 

Investors:

Media:

Shanye Hudson 516-677-0200 x1272

Jeffrey Pina 516-677-0200 x1222

shudson@veeco.com

jpina@veeco.com

 



 

Veeco Instruments Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

 

 

 

Three months ended December 31,

 

For the year ended December 31,

 

 

 

2015

 

2014

 

2015

 

2014

 

Net sales

 

$

106,543

 

$

113,569

 

$

477,038

 

$

392,873

 

Cost of sales

 

67,757

 

75,695

 

299,797

 

257,991

 

Gross profit

 

38,786

 

37,874

 

177,241

 

134,882

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

Selling, general, and administrative

 

21,036

 

24,490

 

90,188

 

89,760

 

Research and development

 

20,639

 

20,424

 

78,543

 

81,171

 

Amortization

 

5,802

 

4,195

 

27,634

 

13,146

 

Restructuring

 

1,170

 

884

 

4,679

 

4,394

 

Asset impairment

 

 

55,306

 

126

 

58,170

 

Changes in contingent consideration

 

 

 

 

(29,368

)

Other, net

 

98

 

(2,848

)

(697

)

(3,182

)

Total operating expenses, net

 

48,745

 

102,451

 

200,473

 

214,091

 

Operating income (loss)

 

(9,959

)

(64,577

)

(23,232

)

(79,209

)

Interest income, net

 

145

 

314

 

586

 

855

 

Income (loss) before income taxes

 

(9,814

)

(64,263

)

(22,646

)

(78,354

)

Income tax expense (benefit)

 

(26

)

(7,351

)

9,332

 

(11,414

)

Net income (loss)

 

$

(9,788

)

$

(56,912

)

$

(31,978

)

$

(66,940

)

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.25

)

$

(1.44

)

$

(0.80

)

$

(1.70

)

Diluted

 

$

(0.25

)

$

(1.44

)

$

(0.80

)

$

(1.70

)

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

Basic

 

39,794

 

39,446

 

39,742

 

39,350

 

Diluted

 

39,794

 

39,446

 

39,742

 

39,350

 

 



 

Veeco Instruments Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(In thousands)

 

 

 

December 31, 2015

 

December 31, 2014

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

269,232

 

$

270,811

 

Short-term investments

 

116,050

 

120,572

 

Restricted cash

 

 

539

 

Accounts receivable, net

 

49,524

 

60,085

 

Inventories

 

77,469

 

61,471

 

Deferred cost of sales

 

2,100

 

5,076

 

Prepaid expenses and other current assets

 

22,760

 

23,132

 

Assets held for sale

 

5,000

 

6,000

 

Deferred income taxes

 

 

7,976

 

Total current assets

 

542,135

 

555,662

 

Property, plant and equipment, net

 

79,590

 

78,752

 

Intangible assets, net

 

131,674

 

159,308

 

Goodwill

 

114,908

 

114,959

 

Deferred income taxes

 

1,384

 

1,180

 

Other assets

 

21,098

 

19,594

 

Total assets

 

$

890,789

 

$

929,455

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

30,074

 

$

18,111

 

Accrued expenses and other current liabilities

 

49,393

 

48,418

 

Customer deposits and deferred revenue

 

76,216

 

96,004

 

Income taxes payable

 

6,208

 

5,441

 

Deferred income taxes

 

 

120

 

Current portion of long-term debt

 

340

 

314

 

Total current liabilities

 

162,231

 

168,408

 

Deferred income taxes

 

11,211

 

16,397

 

Long-term debt

 

1,193

 

1,533

 

Other liabilities

 

1,539

 

4,185

 

Total liabilities

 

176,174

 

190,523

 

 

 

 

 

 

 

Total stockholders’ equity

 

714,615

 

738,932

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

890,789

 

$

929,455

 

 



 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(In thousands, except per share data)

(Unaudited)

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

Three months ended December 31, 2015

 

GAAP

 

Share-based
Compensation

 

Acquisition
Related

 

Other

 

Non-GAAP

 

Net sales

 

$

106,543

 

$

 

$

 

$

 

$

106,543

 

Cost of sales

 

67,757

 

(393

)

 

 

67,364

 

Gross profit

 

38,786

 

393

 

 

 

39,179

 

Gross margin

 

36.4

%

 

 

 

 

 

 

36.8

%

Operating expenses, net:

 

 

 

 

 

 

 

 

 

 

 

Selling, general, and administrative

 

21,036

 

(2,277

)

(188

)

 

18,571

 

Research and development

 

20,639

 

(1,292

)

 

 

19,347

 

Amortization

 

5,802

 

 

(5,802

)

 

 

Restructuring

 

1,170

 

 

 

(1,170

)

 

Other, net

 

98

 

 

 

 

98

 

Total operating expenses, net

 

48,745

 

(3,569

)

(5,990

)

(1,170

)

38,016

 

Operating income (loss)

 

(9,959

)

3,962

 

5,990

 

1,170

 

1,163

 

Interest income, net

 

145

 

 

 

 

145

 

Income (loss) before income taxes

 

(9,814

)

3,962

 

5,990

 

1,170

 

1,308

 

Income tax expense (benefit)

 

(26

)

 

 

760

(a)

734

 

Net income (loss)

 

$

(9,788

)

$

3,962

 

$

5,990

 

$

410

 

$

574

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

$

(0.25

)

 

 

 

 

 

 

$

0.01

 

Diluted earnings per share

 

$

(0.25

)

 

 

 

 

 

 

$

0.01

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

Basic shares

 

39,794

 

 

 

 

 

 

 

40,644

 

Diluted shares

 

39,794

 

 

 

 

 

 

 

40,731

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP operating income

 

 

 

 

 

 

 

 

 

$

1,163

 

Depreciation

 

 

 

 

 

 

 

 

 

3,282

 

Adjusted EBITDA

 

 

 

 

 

 

 

 

 

$

4,445

 

 


Note:  Amounts may not calculate precisely due to rounding.

 

(a) Primarily due to a change in deferred tax liabilities related to the PSP acquisition.

 

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; nonrecurring charges relating to restructuring initiatives, non-cash asset impairments, certain other non-operating gains and losses, and acquisition-related items such as one-time transaction costs, non-cash amortization of acquired intangible assets, incremental nonrecurring compensation, and the stepped-up cost of sales associated with the purchase accounting of acquired inventory.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 



 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(In thousands, except per share data)

(Unaudited)

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

Three months ended December 31, 2014

 

GAAP

 

Share-based
Compensation

 

Acquisition
Related

 

Other

 

Non-GAAP

 

Net sales

 

$

113,569

 

$

 

$

 

$

 

$

113,569

 

Cost of sales

 

75,695

 

(657

)

(5,175

)(a)

 

69,863

 

Gross profit

 

37,874

 

657

 

5,175

 

 

43,706

 

Gross margin

 

33.3

%

 

 

 

 

 

 

38.5

%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Selling, general, and administrative

 

24,490

 

(2,667

)

(3,242

)(b)

 

18,581

 

Research and development

 

20,424

 

(1,185

)

 

 

19,239

 

Amortization

 

4,195

 

 

(4,195

)

 

 

Restructuring

 

884

 

 

 

(884

)

 

Asset impairment

 

55,306

 

 

 

(55,306

)

 

Other, net

 

(2,848

)

 

 

3,142

(c)

294

 

Total operating expenses, net

 

102,451

 

(3,852

)

(7,437

)

(53,048

)

38,114

 

Operating income (loss)

 

(64,577

)

4,509

 

12,612

 

53,048

 

5,592

 

Interest income, net

 

314

 

 

 

 

314

 

Income (loss) before income taxes

 

(64,263

)

4,509

 

12,612

 

53,048

 

5,906

 

Income tax expense (benefit)

 

(7,351

)

 

2,705

(d)

5,428

(e)

782

 

Net income (loss)

 

$

(56,912

)

$

4,509

 

$

9,907

 

$

47,620

 

$

5,124

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

$

(1.44

)

 

 

 

 

 

 

$

0.13

 

Diluted earnings per share

 

$

(1.44

)

 

 

 

 

 

 

$

0.13

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

Basic shares

 

39,446

 

 

 

 

 

 

 

39,446

 

Diluted shares

 

39,446

 

 

 

 

 

 

 

40,072

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP operating income

 

 

 

 

 

 

 

 

 

$

5,592

 

Depreciation

 

 

 

 

 

 

 

 

 

2,728

 

Adjusted EBITDA

 

 

 

 

 

 

 

 

 

$

8,320

 

 


Note:  Amounts may not calculate precisely due to rounding.

 

(a) The inventory fair value step-up associated with the PSP acquisition’s purchase accounting.

(b) One-time PSP acquisition related transaction costs.

(c) One-time cumulative translation gain related to the liquidation of our Japanese subsidiary.

(d) Valuation allowance reversal associated with the recognition of deferred tax liabilities related to the PSP acquisition.

(e) $4.9 million tax liability reversal related to an incentive tax rate in a foreign subsidiary as well as utilization of the ‘with or without’ method.

 

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; nonrecurring charges relating to restructuring initiatives, non-cash asset impairments, certain other non-operating gains and losses, and acquisition-related items such as one-time transaction costs, non-cash amortization of acquired intangible assets, incremental nonrecurring compensation, and the stepped-up cost of sales associated with the purchase accounting of acquired inventory.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 



 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(In thousands, except per share data)

(Unaudited)

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

For the year ended December 31, 2015

 

GAAP

 

Share-based
Compensation

 

Acquisition
Related

 

Other

 

Non-GAAP

 

Net sales

 

$

477,038

 

$

 

$

 

$

 

$

477,038

 

Cost of sales

 

299,797

 

(2,495

)

(1,311

)(a)

 

295,991

 

Gross profit

 

177,241

 

2,495

 

1,311

 

 

181,047

 

Gross margin

 

37.2

%

 

 

 

 

 

 

38.0

%

Operating expenses, net:

 

 

 

 

 

 

 

 

 

 

 

Selling, general, and administrative

 

90,188

 

(11,474

)

(563

)

 

78,151

 

Research and development

 

78,543

 

(4,031

)

 

 

74,512

 

Amortization

 

27,634

 

 

(27,634

)

 

 

Restructuring

 

4,679

 

 

 

(4,679

)

 

Asset impairment

 

126

 

 

 

(126

)

 

Other, net

 

(697

)

 

 

(395

)(b)

(1,092

)

Total operating expenses, net

 

200,473

 

(15,505

)

(28,197

)

(5,200

)

151,571

 

Operating income (loss)

 

(23,232

)

18,000

 

29,508

 

5,200

 

29,476

 

Interest income, net

 

586

 

 

 

 

586

 

Income (loss) before income taxes

 

(22,646

)

18,000

 

29,508

 

5,200

 

30,062

 

Income tax expense (benefit)

 

9,332

 

 

 

(1,334

)(c)

7,998

 

Net income (loss)

 

$

(31,978

)

$

18,000

 

$

29,508

 

$

6,534

 

$

22,064

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

$

(0.80

)

 

 

 

 

 

 

$

0.54

 

Diluted earnings per share

 

$

(0.80

)

 

 

 

 

 

 

$

0.54

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

Basic shares

 

39,742

 

 

 

 

 

 

 

40,759

 

Diluted shares

 

39,742

 

 

 

 

 

 

 

40,905

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP operating income

 

 

 

 

 

 

 

 

 

$

29,476

 

Depreciation

 

 

 

 

 

 

 

 

 

12,216

 

Adjusted EBITDA

 

 

 

 

 

 

 

 

 

$

41,692

 

 


Note:  Amounts may not calculate precisely due to rounding.

 

(a) The inventory fair value step-up associated with the PSP acquisition’s purchase accounting.

(b) The non-GAAP adjustment relates to a one-time legal settlement.

(c) Primarily due to a change in deferred tax liabilities related to the PSP acquisition.

 

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; nonrecurring charges relating to restructuring initiatives, non-cash asset impairments, certain other non-operating gains and losses, and acquisition-related items such as one-time transaction costs, non-cash amortization of acquired intangible assets, incremental nonrecurring compensation, and the stepped-up cost of sales associated with the purchase accounting of acquired inventory.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 



 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(In thousands, except per share data)

(Unaudited)

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

For the year ended December 31, 2014

 

GAAP

 

Share-based
Compensation

 

Acquisition
Related

 

Other

 

Non-GAAP

 

Net sales

 

$

392,873

 

$

 

$

 

$

 

$

392,873

 

Cost of sales

 

257,991

 

(2,456

)

(5,175

)(a)

 

250,360

 

Gross profit

 

134,882

 

2,456

 

5,175

 

 

142,513

 

Gross margin

 

34.3

%

 

 

 

 

 

 

36.3

%

Operating expenses, net:

 

 

 

 

 

 

 

 

 

 

 

Selling, general, and administrative

 

89,760

 

(11,859

)

(3,242

)(b)

 

74,659

 

Research and development

 

81,171

 

(4,498

)

 

 

76,673

 

Amortization

 

13,146

 

 

(13,146

)

 

 

Restructuring

 

4,394

 

 

 

(4,394

)

 

Asset impairment

 

58,170

 

 

 

(58,170

)

 

Changes in contingent consideration

 

(29,368

)

 

 

29,368

 

 

Other, net

 

(3,182

)

 

 

3,142

(c)

(40

)

Total operating expenses, net

 

214,091

 

(16,357

)

(16,388

)

(30,054

)

151,292

 

Operating income (loss)

 

(79,209

)

18,813

 

21,563

 

30,054

 

(8,779

)

Interest income, net

 

855

 

 

 

 

855

 

Income (loss) before income taxes

 

(78,354

)

18,813

 

21,563

 

30,054

 

(7,924

)

Income tax expense (benefit)

 

(11,414

)

 

2,705

(d)

4,908

(e)

(3,801

)

Net income (loss)

 

$

(66,940

)

$

18,813

 

$

18,858

 

$

25,146

 

$

(4,123

)

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

$

(1.70

)

 

 

 

 

 

 

$

(0.10

)

Diluted earnings per share

 

$

(1.70

)

 

 

 

 

 

 

$

(0.10

)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

Basic shares

 

39,350

 

 

 

 

 

 

 

39,350

 

Diluted shares

 

39,350

 

 

 

 

 

 

 

39,350

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP operating income

 

 

 

 

 

 

 

 

 

$

(8,779

)

Depreciation

 

 

 

 

 

 

 

 

 

11,426

 

Adjusted EBITDA

 

 

 

 

 

 

 

 

 

$

2,647

 

 


Note:  Amounts may not calculate precisely due to rounding.

 

(a) The inventory fair value step-up associated with the PSP acquisition’s purchase accounting.

(b) One-time PSP acquisition related transaction costs.

(c) One-time cumulative translation gain related to the liquidation of our Japanese subsidiary.

(d) Valuation allowance reversal associated with the recognition of deferred tax liabilities related to the PSP acquisition.

(e) $4.9 million tax liability reversal related to an incentive tax rate in a foreign subsidiary as well as utilization of the ‘with or without’ method.

 

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; nonrecurring charges relating to restructuring initiatives, non-cash asset impairments, certain other non-operating gains and losses, and acquisition-related items such as one-time transaction costs, non-cash amortization of acquired intangible assets, incremental nonrecurring compensation, and the stepped-up cost of sales associated with the purchase accounting of acquired inventory.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 



 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(In millions, except per share data)

(Unaudited)

 

 

 

 

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

 

 

 

 

Guidance for the three months ended March 31, 2016

 

GAAP

 

Share-based
Compensation

 

Acquisition
Related

 

Non-GAAP

 

Net sales

 

$

70

 

-

 

$

80

 

$

––

 

$

––

 

$

70

 

-

 

$

80

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

25

 

-

 

30

 

1

 

––

 

26

 

-

 

31

 

Gross margin

 

36

%

-

 

38

%

 

 

 

 

37

%

-

 

39

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

(23

)

-

 

(19

)

5

 

5

 

(13

)

-

 

(9

)

Depreciation

 

 

 

 

 

 

 

 

 

 

 

4

 

 

 

4

 

Adjusted EBITDA

 

 

 

 

 

 

 

 

 

 

 

$

(9

)

-

 

$

(5

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

(24

)

-

 

(20

)

5

 

5

 

(14

)

-

 

(10

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per diluted common share

 

$

(0.62

)

-

 

$

(0.52

)

 

 

 

 

$

(0.35

)

-

 

$

(0.25

)

Weighted average number of shares

 

39

 

 

 

39

 

 

 

 

 

39

 

 

 

39

 

 

Note:  Amounts may not calculate precisely due to rounding.

 

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; nonrecurring charges relating to restructuring initiatives, non-cash asset impairments, certain other non-operating gains and losses, and acquisition-related items such as one-time transaction costs, non-cash amortization of acquired intangible assets, incremental nonrecurring compensation, and the stepped-up cost of sales associated with the purchase accounting of acquired inventory.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.